retatrutide mechanism triple agonist glp-1 gip glucagon receptor Why target one pathway when you can master three? 🎯 ​Introducing Reta-HUB® (Retatrutide) — The GIP/ GLP-1/ that's setting a new standard in metabolic care. ​ Glucagon-like peptide-1 receptor agonists in

This activation inhibits intracellular serine/threonine kinases, like JNK, which in turn reduces insulin receptor substrate (IRS)-1 serine phosphorylation, a major contributor to insulin resistance, and decreases atherosclerosis

Store in a cool, dry place for optimal efficacy

Patients with diabetes or prediabetes should monitor blood glucose closely Theoretical cancer concern: improved IGF-1 has been associated with certain cancer risks in epidemiological studies

Studies show that men with low levels of glutathione are more prone to erectile dysfunction

Bendahan D, Mattei JP, Ghattas B, Confort-Gouny S, Le Guern ME, Cozzone PJ

Other Ingredients: Water, Malt Syrup, Organic Fruity Extraction, Pectin, Citric Acid, Lactic Acid, Sodium Citrate